Akebia Therapeutics Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Akebia Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $4.20. The average 1-year stock price forecast is 292.52% higher than the current stock price, while the lowest is $3.00 (+180.37%) and the highest is $6.00 (+460.75%).

Price Target: $4.20 (+292.52%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$4.20	$4.00	$6.00
Change	+180.37%	+292.52%	+273.83%	+460.75%

* Price targets were last updated on May 8, 2026.

Analyst Ratings

The average analyst rating for Akebia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	4	4	4	4	4	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Caufield H.C. Wainwright	H.C. Wainwright	Buy Reiterates $6	Buy	Reiterates	$6	+460.75%	May 8, 2026
Allison Bratzel Piper Sandler	Piper Sandler	Buy Maintains $4	Buy	Maintains	$4	+273.83%	Apr 24, 2026
Julian Harrison BTIG	BTIG	Buy Maintains $4	Buy	Maintains	$4	+273.83%	Apr 7, 2026

Financial Forecast

Revenue This Year

206.64M

from 236.20M

-12.51%

from 236.20M

Revenue Next Year

159.90M

from 206.64M

-22.62%

from 206.64M

EPS This Year

-0.11

from -0.02

EPS Next Year

-0.19

from -0.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	211.65M	292.48M	194.62M	160.18M	236.20M	206.64M
Revenue Growth	-28.17%	38.19%	-33.46%	-17.70%	47.46%	-12.51%
Gross Profit	130.16M	269.99M	154.86M	134.03M	195.84M	165.31M
Gross Margin	61.50%	92.31%	79.57%	83.68%	82.92%	80.00%
Operating Income	-227.88M	-34.64M	-44.50M	-46.21M	26.00M	-30.05M
Net Income	-282.02M	-94.23M	-51.93M	-69.41M	-5.35M	-40.21M
EPS	-	-	-	-	-0.02	-0.11
Free Cash Flow	-136.04M	-15.30M	17.90M	13.63M	68.61M	-30.76M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	218.6M
Avg	206.6M
Low	172.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-7.4%
Avg	-12.5%
Low	-27.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.11
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-